Skip to main content
RACS ASC 2026
Does the introduction of combination chemotherapy and targeted agents improve overall survival in pancreatic adenocarcinoma?
Invited Paper

Invited Paper

4:20 pm

02 May 2026

Bellevue Ballroom 2

PANCREATIC MALIGNANCY: HAS ANYTHING CHANGED?

Disciplines

HPB Surgery

Presenters